Following recommendations by the World Health Organization in 2015, and key clinical
trials, countries in sub-Saharan Africa, the region with the highest burden of human …

In light of the increasing global burden of new HIV infections, growing financial
requirements, and shifting funding landscape, the global health community must accelerate …

Background Pre-exposure prophylaxis (PrEP) is highly effective and an important prevention
tool for African adolescent girls and young women (AGYW), but adherence and persistence …

These guidelines for the treatment of persons who have or are at risk for sexually transmitted
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …

Introduction HIV incidence remains high among African adolescent girls and young women
(AGYW). The primary objective of this study is to assess pre‐exposure prophylaxis (PrEP) …

Background Young women account for a disproportionate fraction of new HIV infections in
Africa and are a priority population for HIV prevention, including implementation of …

Summary Background The Ring Study, a phase 3 trial in 1959 sexually active women
(randomised 2: 1), showed a favourable safety profile and a 31% HIV-1 infection risk …

Introduction: Existing biomedical HIV prevention options, though highly effective, present
substantial adherence challenges. End-user input on early-stage design of new HIV …

In this guideline, WHO recommends that long-acting injectable cabotegravir (CAB-LA) may
be offered as an additional HIV prevention option for people at substantial risk of HIV …

Background Strengthening HIV prevention is imperative given the continued high HIV
incidence worldwide. The introduction of oral PrEP as a new biomedical HIV prevention tool …